A carregar...
Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
Novel cardioprotective agents are needed in both heart failure (HF) and myocardial infarction. Increasing evidence from cellular studies and animal models indicate protective effects of phosphodiesterase-5 (PDE5) inhibitors, drugs usually reserved as treatments of erectile dysfunction and pulmonary...
Na minha lista:
| Publicado no: | Heart |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204975/ https://ncbi.nlm.nih.gov/pubmed/29519873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2017-312865 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|